Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank29
3Y CAGR-13.8%
5Y CAGR-8.8%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-13.8%/yr
vs +91.5%/yr prior
5Y CAGR
-8.8%/yr
Recent deceleration
Acceleration
-105.3pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $141.31M | -19.5% |
| 2024 | $175.51M | -36.8% |
| 2023 | $277.67M | +25.9% |
| 2022 | $220.50M | -27.7% |
| 2021 | $305.10M | +36.5% |
| 2020 | $223.59M | +922.3% |
| 2019 | $21.87M | +33.3% |
| 2018 | $16.41M | - |